Allergic Rhinitis

12/05/2013 - "However, there are now many meta-analyses, systematic reviews and high-quality clinical trials that find overwhelmingly in favor of the efficacy of allergen immunotherapy (including sublingual formulations) in allergic rhinitis induced by pollen and, increasingly, other allergens. "
09/01/2014 - "Although environmental control measures reduce allergen exposure levels, significant alleviation in symptoms or improvement in quality of life in patients with allergic rhinitis have not been shown. "
08/01/2004 - "The increase in airflow in response to treatment was roughly 20% in the blocker group compared with only about 10% in the placebo group, relative to an airflow rate (299 mL/s) measured after provocation on day 1. The blocker was significantly more effective than placebo and reduced the typical symptoms of allergic rhinitis in response to nasal challenge with allergen by nearly 60% (placebo reduced symptoms by 25%). "
01/01/2022 - "Allergen immunotherapy (AIT) is an effective treatment for allergic rhinitis, inducing long-term clinical tolerance to the sensitizing allergen. "
05/01/2010 - "Although nasal challenge with allergen has often been used to evaluate the efficacy of therapeutic modalities used for the treatment of allergic rhinitis, the reproducibility of this model in quantitatively evaluating efficacy has not been rigorously examined. "

02/01/2010 - "Intranasal corticosteroids are the most effective treatment for allergic rhinitis based on meta-analyses of clinical trials; however, the population in such trials is restricted and may not be representative of patients who are later treated with the medication. "
01/01/2022 - "Intranasal corticosteroid (INCS) is one of the most effective treatments for allergic rhinitis (AR). "
07/01/2015 - "Intranasal corticosteroids are generally considered the most effective medication class for controlling allergic rhinitis. "
03/01/2014 - "Intranasal corticosteroids are the most effective medication class for controlling allergic rhinitis (AR) symptoms. "
11/01/2013 - "Guidelines from throughout the world recommend intranasal corticosteroids (INSs) as first-line treatment for most patients with moderate to severe allergic rhinitis. "

01/01/2021 - "Allergic rhinitis is a condition with high global prevalence most effectively treated with antihistamines and antileukotrienes. "
12/01/1992 - "The older, classic antihistamines are effective in treating the symptoms of allergic rhinitis, but most are sedating because they cross the blood-brain barrier. "
12/01/2007 - "Oral antihistamines have proven efficacy in treating ocular symptoms of allergic rhinitis."
07/01/2023 - "Oral H1 antihistamines are the first-line treatment for patients with allergic rhinitis, while it is uncertain which kind and dosage of the antihistamines are more effective in improving symptoms of patients. "
12/01/2007 - "Antihistamines are an established first-line treatment for allergic rhinitis and are widely prescribed in infants for allergic symptoms. "

01/01/2012 - "Compound 22 significantly improved symptoms of allergic rhinitis and suppressed levels of total IgE of serum. "
11/01/2020 - "Our primary gold standard of allergic rhinitis was a positive serum specific IgE (≥0.35) and self-reported nasal symptoms retrieved from two general health examination studies conducted in Danish adults (18-69 years) during 2006 to 2008 (n = 3416) and 2012 to 2015 (n = 7237). "
05/11/2023 - "Several novel studies have shown that it is possible to use the assessment of nasal sIgE (specific immunoglobulin E) secretion as an additional diagnostic criterion for local allergic rhinitis. "
12/01/2020 - "Objective:To study the role of gut microbiota in children with allergic rhinitis with high serum total IgE level. "
01/01/2020 - "This was a multicenter, open-label, randomized trial of 109 Japanese patients with coexisting HDM and JCP allergic rhinitis who had positive tests for HDM- and JCP specific IgE (≥0.7 kU/L). "

02/01/2003 - "The treatment effect of montelukast was significantly greater (P < 0.05), relative to placebo, for all secondary endpoints, including nighttime symptoms and daytime eye symptoms, patient and physician global evaluations of allergic rhinitis, and rhinoconjunctivitis quality of life. "
12/01/2005 - "Montelukast treatment also improved global evaluations of allergic rhinitis by patients and Rhinoconjunctivitis Quality of Life Questionnaire scores: differences vs the placebo group were -0.15 (95% CI, -0.27 to -0.04; P < .01) and -0.15 (95% CI, -0.24 to -0.06; P < .001), respectively. "
06/01/2006 - "Recent studies have demonstrated that montelukast is also effective in treating daytime and nighttime allergic rhinitis (AR) symptoms in asthmatic patients. "
02/01/2022 - "Is montelukast monotherapy effective for the management of allergic rhinitis in children?"
03/25/2020 - "Conclusions The common symptoms of allergic rhinitis evaluated in the study showed improvement in response to the treatment with montelukast. "

06/01/2010 - "The reader will gain a better understanding of the pharmacology of OLO nasal spray, the clinical trial data that have established the efficacy of OLO nasal spray and the overall role of OLO nasal spray in the management of allergic rhinitis. "
12/30/2020 - "In this study, we analyzed instructional videos available on YouTube for the administration of nasal sprays for allergic rhinitis. "
01/20/2017 - "Objective:To study the effect of nasal spray on the clinical symptoms and the level of inflammatory factors in patients with allergic rhinitis by salines with different temperature normal salines.Method"
02/01/1998 - "This double-blind, placebo-controlled study compared the effect of once-daily TAA aqueous nasal spray (220 or 440 microg) with placebo on adrenocortical function after 6 weeks of treatment in pediatric (children 6 to 12 years of age) patients with allergic rhinitis. "
10/28/2023 - "Managing Children with Allergic Rhinitis: A Preliminary Experience with a New Multicomponent Nasal Spray."

01/01/2022 - "Intranasal steroid (INS) is the most effective medication class for controlling allergic rhinitis (AR) symptoms; however, its effectiveness is limited by patient compliance. "
11/01/2013 - "In general, limited comparative studies between different INSs have not indicated that one particular steroid moiety is more effective than another in controlling symptoms of allergic rhinitis. "
05/01/2006 - "Intranasal steroids (INSs) are recommended as first-line treatment for allergic rhinitis (AR) and a wealth of data exist supporting them as safe and effective. "
01/01/2019 - "Intranasal steroids (INS) are effective in treating allergic rhinitis, but their effect on IL-25 release has not been studied. "
03/01/2015 - "Intranasal steroids are recognized as an effective treatment for allergic rhinitis (AR) although their effect on nasal patency has never been evaluated with an objective instrument such as anterior rhinomanometry in children. "

02/01/1997 - "Azelastine is a selective H1-receptor antagonist, which has previously been demonstrated to be effective in the treatment of allergic rhinitis. "
01/01/1996 - "In conclusion, these results suggest that Allergodil is an effective treatment of the symptoms of allergic rhinitis in children. "
05/01/2022 - "The purpose of our study was to assess the safety and efficacy of MP-AzeFlu for the treatment of allergic rhinitis, compared to placebo and azelastine monotherapy. "
04/01/1998 - "[Efficacy of topical azelastine in the treatment of allergic rhinitis caused by Parietaria officinalis]."
07/04/2023 - "The outcome obtained in this study indicated that azelastine nanosuspension has great potential to treat allergic rhinitis as intranasal treatment."

01/01/2021 - "In this case, omalizumab markedly improved ASD-related and sleep behavior in a 6-year-old with ASD, allergic rhinitis, and autoimmune disorder. "
09/01/2023 - "Omalizumab effectively treated patients with moderate-to-severe allergic rhinitis, and improved their quality of life."
05/05/2016 - "[Safety and efficacy of omalizumab for the treatment of allergic rhinitis:Meta-analysis of randomized clinical trials]."
05/01/2014 - "Studies on the efficacy of omalizumab in allergic rhinitis that assessed clinical outcomes were selected. "
12/01/2016 - "Our data confirm the efficacy of omalizumab in the treatment of allergic rhinitis. "

02/01/2016 - "Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial."
01/01/2021 - "The 300 IR sublingual HDM tablet is an effective, safe treatment for HDM-induced allergic rhinitis."
03/01/2017 - "House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis."
02/01/2016 - "The efficacy of these sublingual immunotherapy tablets in the treatment of allergic rhinitis has been firmly established in large multicenter clinical trials. "
06/01/2014 - "Preliminary studies have suggested the efficacy of sublingual tablets of house dust mite (HDM) extracts in adults with allergic rhinitis. "

02/01/2000 - "Most authors consider immunotherapy as an efficient and safe treatment for pollen and mite allergic rhinitis. "
04/01/2018 - "While specific immunotherapy (SIT) has been proven to be cost-effective for the treatment of allergic rhinitis compared to symptomatic treatment, there is a lack of European studies in which sublingual (SLIT) and subcutaneous (SCIT) immunotherapy were compared. "
11/01/2021 - "The efficacy of subcutaneous immunotherapy (SCIT) for allergic rhinitis (AR) have been proven but application is still limited by concerns about the safety. "
11/01/2018 - ": Mixed immunotherapy with dust mites and alternaria was effective and safe in allergic rhinitis patients and it had better curative effect than medication."
01/01/2015 - "House dust mite (HDM) immunotherapy has proven efficacy in treating allergic rhinitis (AR) symptoms. "

02/01/2004 - "The results of this comparative study demonstrate that FPANS is highly effective for treating patients affected by allergic rhinitis, with efficacy exceeding that of CTZ plus MSK in combined therapy. "
01/01/2016 - "The genetic polymorphism (SNPs) of four important functional candidate genes( FOXP3, IL-2, TGF-βand EBI3) in T regulatory cells signaling pathways were detected in significant correlation with the efficacy of allergic rhinitis specific immune therapy."
08/01/2011 - "The strategy for H-PGDS inhibition may be beneficial for allergic rhinitis therapy."
11/01/2019 - "Conclusion: Though sublingual immunotherapy may be more expensive than conventional treatments, it was an adjunctive therapy that improved not only the outcomes for allergic rhinitis, but also its comorbid allergic conditions."
01/01/2009 - "With regard to the cost implications of continuous therapy versus on-demand therapy, there are indications that effective treatment of allergic rhinitis by continuous treatment reduces overall drug costs, particularly that of escape medication and indirect costs in the form of days absent from work and school."

10/01/2022 - "Pharmacotherapy forms mainstay of treatment for allergic rhinitis, and has adverse effects associated with it. "
11/09/2022 - "Allergen immunotherapy is the only fundamental treatment that modifies the natural course of allergic rhinitis and provides long-term remission that cannot be induced by general drug therapy. "
09/01/2021 - "Improvement in Psychological Condition of Patients With Persistent Moderate-Severe Allergic Rhinitis by Drug Therapy Combined With Psychological Intervention."
02/01/1998 - "This article provides guidelines for pharmacotherapy to maximize symptom relief from allergic rhinitis. "
01/01/2013 - "The objective of the present study was to analyse modern concepts of pathogenesis od local immune changes in nasal mucosa associated with allergic rhinitis (AR)and the currently available methods for rational pharmacotherapy of this condition. "

01/01/2010 - "This study supports the belief that the acupoint herbal patch is an effective treatment for allergic rhinitis and can significantly improve general health, social life and vitality in quality of life."
12/01/2022 - "To use evidence-based medicine to explore the efficacy of acupoint application (AA) for allergic rhinitis (AR) at different time points and its safety. "
06/25/2017 - "To observe the efficacy of acupuncture at phenomaxillary ganglia and local acupoints for symptoms induced by allergic rhinitis (AR). "
09/01/2012 - "Influencing factors on efficacy of summer acupoint application treatment for allergic rhinitis: a retrospective study."
12/01/2022 - "Efficacy and safety of acupoint application for allergic rhinitis: a systematic review and Meta-analysis of randomized controlled trials."

10/05/2018 - "Conclusion:The unilateral vidian neurectomy following endoscopic trans-sphenoethmoidal recess approach is an safe and effective technique in the management of moderate severe allergic rhinitis,and unilateral surgery could relieve bilateral nasal symptoms."
05/01/2012 - "In the hands of a well-trained surgeon bilateral endoscopic vidian neurectomy is an effective and safe technique in the management of moderate to severe persistent allergic rhinitis."
06/01/2011 - "Endoscopic vidian neurectomy is an effective and safe technique in the management of moderate-severe persistent allergic rhinitis."
05/01/2012 - "To evaluate the long-term efficacy of bilateral endoscopic vidian neurectomy in the management of moderate to severe persistent allergic rhinitis. "
06/01/2011 - "To evaluate the efficacy of endoscopic vidian neurectomy in the management of moderate-severe persistent allergic rhinitis, and to explore its possible mechanism. "